Circulating tumour DNA (ctDNA)-based biomarkers for predicting response to treatment in metastatic HER2-positive (HER2+) and triple-negative breast cancer (TNBC) (WP4)

Lidia Trombello

Gallery

Lidia Trombello

Lidia TrombelloEstel Aparicio Prat2026-03-04T11:21:47+00:00

This project has received funding from the European Union’s Horizon Europe programme under grant agreement 101169223

This project has received funding from the European Union’s Horizon Europe programme under grant agreement 101169223.Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the Research Executive Agency (REA). Neither the European Union nor the granting authority can be held responsible for them.